Ellington Management Group’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-55,000
| Closed | -$471K | – | 683 |
|
|
2018
Q1 | $471K | Buy |
+55,000
| New | +$471K | 0.03% | 411 |
|
|
2017
Q4 | – | Sell |
-24,100
| Closed | -$296K | – | 713 |
|
|
2017
Q3 | $296K | Buy |
+24,100
| New | +$296K | 0.05% | 377 |
|
|
2016
Q3 | – | Sell |
-11,700
| Closed | -$168K | – | 666 |
|
|
2016
Q2 | $168K | Sell |
11,700
-15,600
| -57% | -$224K | 0.23% | 175 |
|
|
2016
Q1 | $326K | Buy |
+27,300
| New | +$326K | 0.14% | 215 |
|
|
2015
Q3 | – | Sell |
-15,000
| Closed | -$121K | – | 809 |
|
|
2015
Q2 | $121K | Buy |
+15,000
| New | +$121K | 0.03% | 638 |
|